Clinical Trial Update: Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and immunogenicity of the Varivax varicella vaccine (2007 process) completed. Results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Varivax (varicella vaccine (live attenuated))

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Varicella | Phase 3 | Status: COMPLETED | Results posted: 2011-04-21